Mark Froimson
CIK: 0001709050
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PCRX
Pacira BioSciences, Inc.
Director
Discretionary Trading P&L
Holdings
About Froimson Mark
Froimson Mark (SEC CIK 0001709050) files insider reports with the SEC as Director of Pacira BioSciences, Inc. (PCRX).
Signal8 holds 3 ownership filings by Froimson Mark, all Form 4s, filed between Jun 13, 2025 and Jun 12, 2026. Those filings report 3 transactions, from Jun 11, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Froimson Mark's filings is in BRISBANE, CA.
Recent filings by Froimson Mark
Other insiders filing for Pacira BioSciences, Inc. (PCRX)
- RIKER LAUREN, Senior Vice President, Finance
- SLONIN JONATHAN, Chief Medical Officer
- Hirawat Samit, Director
- CHRISTIE CHRISTOPHER, Director
- WIGGANS THOMAS G, Director
- Young Alethia, Director